These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20934654)

  • 1. Different effects of thiazolidinediones on target vessel revascularization with bare metal stents: a meta-analysis.
    Nishio K; Kobayashi Y
    Cardiovasc Revasc Med; 2010; 11(4):227-31. PubMed ID: 20934654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pioglitazone in the prevention of restenosis and need for revascularization after bare-metal stent implantation: a meta-analysis.
    Patel D; Walitt B; Lindsay J; Wilensky RL
    JACC Cardiovasc Interv; 2011 Mar; 4(3):353-60. PubMed ID: 21435616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone to reduce restenosis after bare-metal stent placement?
    Nissen SE
    JACC Cardiovasc Interv; 2009 Jun; 2(6):532-3. PubMed ID: 19539257
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis.
    Riche DM; Valderrama R; Henyan NN
    Diabetes Care; 2007 Feb; 30(2):384-8. PubMed ID: 17259517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of diabetics receiving bare-metal stents versus drug-eluting stents.
    Ramanath VS; Brown JR; Malenka DJ; DeVries JT; Sidhu MS; Robb JF; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Thompson CA;
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):473-81. PubMed ID: 20882647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
    Park SJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):184. PubMed ID: 17630660
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.
    Geng DF; Jin DM; Wu W; Wang Z; Wang JF
    Atherosclerosis; 2009 Feb; 202(2):521-8. PubMed ID: 18602105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials.
    Agostoni P; Biondi-Zoccai GG; Gasparini GL; Anselmi M; Morando G; Turri M; Abbate A; McFadden EP; Vassanelli C; Zardini P; Colombo A; Serruys PW
    Eur Heart J; 2005 May; 26(9):881-9. PubMed ID: 15681573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
    Mahmud E; Bromberg-Marin G; Palakodeti V; Ang L; Creanga D; Demaria AN
    J Am Coll Cardiol; 2008 Jun; 51(25):2385-95. PubMed ID: 18565394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.